Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Metabolic Benefits of Six-month Thiamine Supplementation in Patients With and Without Diabetes Mellitus Type 2.

Al-Attas O, Al-Daghri N, Alokail M, Abd-Alrahman S, Vinodson B, Sabico S.

Clin Med Insights Endocrinol Diabetes. 2014 Jan 23;7:1-6. doi: 10.4137/CMED.S13573. eCollection 2014.

PMID:
24550684
[PubMed]
Free PMC Article
2.

Blood thiamine and its phosphate esters as measured by high-performance liquid chromatography: levels and associations in diabetes mellitus patients with varying degrees of microalbuminuria.

Al-Attas OS, Al-Daghri NM, Alfadda AA, Abd-Alrahman SH, Sabico S.

J Endocrinol Invest. 2012 Dec;35(11):951-6. doi: 10.3275/8126. Epub 2011 Nov 22.

PMID:
22107884
[PubMed - indexed for MEDLINE]
3.

Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.

Alkharfy KM, Al-Daghri NM, Sabico SB, Al-Othman A, Moharram O, Alokail MS, Al-Saleh Y, Kumar S, Chrousos GP.

Cardiovasc Diabetol. 2013 Aug 7;12:113. doi: 10.1186/1475-2840-12-113.

PMID:
23924389
[PubMed - in process]
Free PMC Article
4.

A 6-month "self-monitoring" lifestyle modification with increased sunlight exposure modestly improves vitamin D status, lipid profile and glycemic status in overweight and obese Saudi adults with varying glycemic levels.

Al-Daghri NM, Alfawaz H, Aljohani NJ, Al-Saleh Y, Wani K, Alnaami AM, Alharbi M, Kumar S.

Lipids Health Dis. 2014 May 26;13:87. doi: 10.1186/1476-511X-13-87.

PMID:
24884616
[PubMed - in process]
Free PMC Article
5.

Vitamin D supplementation as an adjuvant therapy for patients with T2DM: an 18-month prospective interventional study.

Al-Daghri NM, Alkharfy KM, Al-Othman A, El-Kholie E, Moharram O, Alokail MS, Al-Saleh Y, Sabico S, Kumar S, Chrousos GP.

Cardiovasc Diabetol. 2012 Jul 18;11(1):85. doi: 10.1186/1475-2840-11-85.

PMID:
22809461
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Thiamine and its phosphate esters in relation to cardiometabolic risk factors in Saudi Arabs.

Al-Daghri NM, Al-Attas OS, Alkharfy KM, Alokail MS, Abd-Alrahman SH, Sabico S.

Eur J Med Res. 2013 Sep 23;18:32. doi: 10.1186/2047-783X-18-32.

PMID:
24059534
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Hypovitaminosis D associations with adverse metabolic parameters are accentuated in patients with Type 2 diabetes mellitus: a body mass index-independent role of adiponectin?

Al-Daghri NM, Al-Attas OS, Alokail MS, Alkharfy KM, Al-Othman A, Draz HM, Yakout SM, Al-Saleh Y, Al-Yousef M, Sabico S, Clerici M, Chrousos GP.

J Endocrinol Invest. 2013 Jan;36(1):1-6. doi: 10.3275/8183. Epub 2011 Dec 15.

PMID:
22183134
[PubMed - indexed for MEDLINE]
8.

Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement.

Esposito V, Di Biase S, Lettiero T, Labella D, Simeone R, Salerno M.

Clin Endocrinol (Oxf). 2004 Nov;61(5):607-11.

PMID:
15521964
[PubMed - indexed for MEDLINE]
9.

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.

PMID:
16259526
[PubMed - indexed for MEDLINE]
10.

Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.

Derosa G, Cicero AF, D'Angelo A, Gaddi A, Ciccarelli L, Piccinni MN, Salvadeo SA, Pricolo F, Ferrari I, Gravina A, Ragonesi PD.

Clin Ther. 2006 May;28(5):679-88. Erratum in: Clin Ther. 2006 Sep;28(9):1483.

PMID:
16861090
[PubMed - indexed for MEDLINE]
11.

Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan.

Jarab AS, Alqudah SG, Mukattash TL, Shattat G, Al-Qirim T.

J Manag Care Pharm. 2012 Sep;18(7):516-26.

PMID:
22971205
[PubMed - indexed for MEDLINE]
Free Article
12.

Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: a twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial.

Derosa G, Cicero AF, Gaddi A, Ragonesi PD, Fogari E, Bertone G, Ciccarelli L, Piccinni MN.

Clin Ther. 2004 May;26(5):744-54.

PMID:
15220018
[PubMed - indexed for MEDLINE]
13.

Elderly people with hypothalamic-pituitary disease and untreated GH deficiency: clinical outcome, body composition, lipid profiles and quality of life after 2 years compared to controls.

Li Voon Chong JS, Groves T, Foy P, Wallymahmed ME, MacFarlane IA.

Clin Endocrinol (Oxf). 2002 Feb;56(2):175-81.

PMID:
11874408
[PubMed - indexed for MEDLINE]
14.

Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes.

Gordon LA, Morrison EY, McGrowder DA, Young R, Fraser YT, Zamora EM, Alexander-Lindo RL, Irving RR.

BMC Complement Altern Med. 2008 May 13;8:21. doi: 10.1186/1472-6882-8-21.

PMID:
18477407
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

High prevalence of metabolic risk factors for cardiovascular diseases among Saudi population, aged 30-64 years.

Rahman Al-Nuaim A.

Int J Cardiol. 1997 Dec 19;62(3):227-35.

PMID:
9476683
[PubMed - indexed for MEDLINE]
16.

Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.

Fattal-Valevski A, Kesler A, Sela BA, Nitzan-Kaluski D, Rotstein M, Mesterman R, Toledano-Alhadef H, Stolovitch C, Hoffmann C, Globus O, Eshel G.

Pediatrics. 2005 Feb;115(2):e233-8.

PMID:
15687431
[PubMed - indexed for MEDLINE]
17.

High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study.

Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, Thornalley PJ.

Diabetologia. 2009 Feb;52(2):208-12. doi: 10.1007/s00125-008-1224-4. Epub 2008 Dec 5.

PMID:
19057893
[PubMed - indexed for MEDLINE]
18.

Effect of oral magnesium supplementation on the lipid profile and blood glucose of patients with type 2 diabetes mellitus.

Lal J, Vasudev K, Kela AK, Jain SK.

J Assoc Physicians India. 2003 Jan;51:37-42.

PMID:
12693452
[PubMed - indexed for MEDLINE]
19.

Lipid response to pioglitazone in diabetic patients: clinical observations from a retrospective chart review.

King AB, Armstrong DU.

Diabetes Technol Ther. 2002;4(2):145-51.

PMID:
12079617
[PubMed - indexed for MEDLINE]
20.

Thiamine supplementation increases serum thiamine and reduces pyruvate and lactate levels in burn patients.

Falder S, Silla R, Phillips M, Rea S, Gurfinkel R, Baur E, Bartley A, Wood FM, Fear MW.

Burns. 2010 Mar;36(2):261-9. doi: 10.1016/j.burns.2009.04.012. Epub 2009 Jun 6.

PMID:
19501976
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk